We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+19.82%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$2.84B
AUM Growth
+$680M
Cap. Flow
+$205M
Cap. Flow %
7.2%
Top 10 Hldgs %
32.58%
Holding
110
New
34
Increased
20
Reduced
17
Closed
25

Top Buys

Rank Stock Value
1
UHS icon
Universal Health Services
UHS
+$55M
2
LLY icon
Eli Lilly
LLY
+$52.4M
3
MCK icon
McKesson
MCK
+$51.5M
4
ACAD icon
Acadia Pharmaceuticals
ACAD
+$41.6M
5
ABBV icon
AbbVie
ABBV
+$40.8M

Top Sells

Rank Stock Value
1
IMMU
Immunomedics Inc
IMMU
+$114M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$30.6M
3
XYZ
Block Inc
XYZ
+$29.5M
4
CNST
Constellation Pharmaceuticals, Inc.
CNST
+$20.8M
5
MSFT icon
Microsoft
MSFT
+$20M

Sector Composition

Rank Sector Weight
1 Healthcare 79.08%
2 Financials 0.38%
3 Consumer Discretionary 0%
4 Industrials 0%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALXN
1
DELISTED
Alexion Pharmaceuticals
ALXN
$153M 5.39%
981,131
+277,314
+39% +$35.6M
OM icon
2
Outset Medical
OM
$78.4M
$151M 5.3%
194,080
+2,547
+1% +$1.96M
ABBV icon
3
AbbVie
ABBV
$454B
$99.3M 3.49%
926,823
+425,073
+85% +$40.8M
HZNP
4
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$97.2M 3.42%
1,328,803
-30,617
-2% -$2.28M
RCUS icon
5
Arcus Biosciences
RCUS
$3.74B
$87.6M 3.08%
3,373,460
+836,528
+33% +$20.2M
ARKG icon
6
PUT
ARK Genomic Revolution ETF
ARKG
$1.55B
$83.9M 2.95%
+900,000
New +$71.7M
ACAD icon
7
Acadia Pharmaceuticals
ACAD
$4.25B
$67.3M 2.37%
1,259,474
+838,387
+199% +$41.6M
IQV icon
8
IQVIA
IQV
$34.6B
$66.9M 2.35%
373,301
+35,314
+10% +$5.95M
UHS icon
9
Universal Health Services
UHS
$9.16B
$60.8M 2.14%
+442,044
New +$55M
LLY icon
10
Eli Lilly
LLY
$1.06T
$59.2M 2.08%
+350,645
New +$52.4M
AVTR icon
11
Avantor
AVTR
$7.75B
$58.4M 2.05%
2,074,259
+804,189
+63% +$20.7M
ICUI icon
12
ICU Medical
ICUI
$3.84B
$57.4M 2.02%
267,817
-35,182
-12% -$6.82M
MRNA icon
13
PUT
Moderna
MRNA
$22.6B
$56.4M 1.98%
540,000
+420,000
+350% +$42.5M
GILD icon
14
Gilead Sciences
GILD
$162B
$54.9M 1.93%
941,674
-136,415
-13% -$8.23M
AZN icon
15
AstraZeneca
AZN
$261B
$54.7M 1.92%
547,300
+353,350
+182% +$37.4M
NVRO
16
DELISTED
NEVRO CORP.
NVRO
$54M 1.9%
311,940
-6,292
-2% -$1.02M
MCK icon
17
McKesson
MCK
$96.5B
$53.7M 1.89%
+308,987
New +$51.5M
ELV icon
18
Elevance Health
ELV
$82.3B
$52.7M 1.86%
164,238
+60,783
+59% +$18.7M
HCA icon
19
HCA Healthcare
HCA
$83.5B
$51.6M 1.81%
313,487
-51,453
-14% -$7.52M
ALXN
20
CALL
DELISTED
Alexion Pharmaceuticals
ALXN
$46.9M 1.65%
+300,000
New +$38.6M
MRTX
21
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$45.9M 1.61%
209,006
-40,062
-16% -$8.66M
EW icon
22
Edwards Lifesciences
EW
$48.3B
$44.5M 1.57%
487,842
– –
HRTX icon
23
Heron Therapeutics
HRTX
$86.9M
$42.6M 1.5%
2,011,477
+139,465
+7% +$2.42M
IRTC icon
24
iRhythm Holdings
IRTC
$3.54B
$40.6M 1.43%
171,028
+4,020
+2% +$916K
THC icon
25
Tenet Healthcare
THC
$17.1B
$39.4M 1.39%
986,019
+144,825
+17% +$4.67M
1
2 3 4 5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return

PFM Health Sciences's Q4 2020 Portfolio in Review

As of Q4 2020, PFM Health Sciences held 110 positions worth $2.84B, up 31% from $2.16B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

PFM Health Sciences deployed $205M of net new capital in Q4 2020, opening 34 new positions and adding to 20 existing holdings. Its largest new stake was Universal Health Services: 442,044 shares worth $60.8M.

By sector, the portfolio is most concentrated in Healthcare at 79% of assets, up from 68% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was BioMarin Pharmaceuticals, an estimated $30.6M trimmed.

  • PFM Health Sciences's largest Q4 2020 buy was Universal Health Services: 442,044 shares worth $60.8M.
  • PFM Health Sciences added most to Acadia Pharmaceuticals in Q4 2020, an estimated $41.6M increase.
  • PFM Health Sciences's biggest Q4 2020 reduction was BioMarin Pharmaceuticals, cutting an estimated $30.6M.
  • PFM Health Sciences fully exited Immunomedics Inc in Q4 2020, selling an estimated $114M.
  • PFM Health Sciences's ten largest holdings make up 33% of its $2.84B portfolio in Q4 2020.
  • PFM Health Sciences opened 34 new positions and closed 25 in Q4 2020.
  • PFM Health Sciences's portfolio value rose 31% quarter-over-quarter to $2.84B.

Based on PFM Health Sciences's 13F filing for Q4 2020, filed 16 Feb 2021.